The effect of an artificial tear combining hyaluronic acid and tamarind seeds polysaccharide in patients with moderate dry eye syndrome: A new treatment for dry eye

European Journal of Ophthalmology

Volumn 24, Issue 2, 2013, Pages 173-178

  Barabino, Stefano ^a   Rolando, Maurizio ^a   Nardi, Marco ^b   Bonini, Stefano ^c   Aragona, Pasquale ^d   Traverso, Carlo Enrico ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF MESSINA   (Italy)

Author keywords

Carmellose sodium; Dry eye disease; Hyaluronic acid; Tamarind seeds polysaccharide; Tear substitutes

Indexed keywords

ARTIFICIAL TEAR; CARBOXYMETHYLCELLULOSE; HYALURONIC ACID; POLYSACCHARIDE; UNCLASSIFIED DRUG; XILOIAL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRY EYE; FEMALE; FOLLOW UP; HUMAN; INJURY; MALE; MIDDLE AGED; MULTICENTER STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TAMARIND;

CONJUNCTIVA; CORNEA; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; DRY EYE SYNDROMES; FEMALE; HUMANS; HYALURONIC ACID; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PHYTOTHERAPY; POLYSACCHARIDES; QUESTIONNAIRES; SEEDS; TAMARINDUS; TEARS;

EID: 84892759120     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.5301/ejo.5000355     Document Type: Article

References (25)

1. Schaumberg DA, Dana R, Buring JE, Sullivan DA. Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies. Arch Ophthalmol 2009;127: 763-8.
2. Buchholz P, Steeds CS, Stern LS, et al. Utility assessment to measure the impact of dry eye disease. Ocul Surf 2006;4: 155-61.
3. Miljanović B, Dana R, Sullivan DA, Schaumberg DA. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol 2007;143:409-15.
4. Huang FC, Tseng SH, Shih MH, Chen FK. Effect of artificial tears on corneal surface regularity, contrast sensitivity, and glare disability in dry eyes. Ophthalmology 2002;109:1934-40.
5. Tiffany JM, Winter N, Bliss G. Tear film stability and tear surface tension. Curr Eye Res 1989;8:507-15.
6. Tiffany JM. Viscoelastic properties of human tears and polymer solutions. Adv Exp Med Biol 1994;350:267-70.
7. Nakamura M, Hikida M, Nakano T, Ito S, Hamano T, Kinoshita S. Characterization of water retentive properties of hyaluronan. Cornea 1993;12:433-6.
8. Aragona P, Papa V, Micali A, Santocono M, Milazzo G. Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye. Br J Ophthalmol 2002;86:181-4.
9. Brignole F, Pisella PJ, Dupas B, Baeyens V, Baudouin C. Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis. Graefes Arch Clin Exp Ophthalmol 2005;243:531-8.
10. Prabhasawat P, Tesavibul N, Kasetsuwan N. Performance profile of sodium hyaluronate in patients with lipid tear deficiency: randomised, double-blind, controlled, exploratory study. Br J Ophthalmol 2007;91:47-50.
11. Gidley MJ, Lillford PJ, Rowlands DW, et al. Structure and solution properties of tamarind-seed polysaccharide. Carbohydr Res 1991;214:299-314.
12. Rolando M, Valente C. Establishing the tolerability and performance of tamarind seed polysaccharide (TSP) in treating dry eye syndrome: results of a clinical study. BMC Ophthalmol 2007;7:5.
13. Uccello-Barretta G, Nazzi S, Zambito Y, Di Colo G, Balzano F, Sanso M. Synergistic interaction between TS-polysaccharide and hyaluronic acid: implications in the formulation of eye drops. Int J Pharm 2010;395:122-31.
14. Versura P, Profazio V, Balducci N, Campos EC. Efficacy of two-month treatment with Xiloial eyedrops for discomfort from disposable soft contact lenses. Clin Ophthalmol 2010; 4:1035-41.
15. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol 2000;118:615-21.
16. Norn MS. Lissamine green. Vital staining of cornea and conjunctiva. Acta Ophthalmol 1973;51:483-91.
17. Lemp MA. Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. CLAO J 1995;21: 221-32.
18. Ousler GW III, Hagberg KW, Schindelar M, Welch D, Abelson MB. The Ocular Protection Index. Cornea 2008;27:509-13.
19. Davitt WF, Bloomenstein M, Christensen M, Martin AE. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation. J Ocul Pharmacol Ther 2010; 26:347-53.
20. Mannucci LL, Fregona I, Mannucci A. Aspetti della cristallizzazione di differenti sostituti lacrimali in uso in Contattologia. EuVision Superficie Oculare 2004;1:6-11.
21. Lindsay B, Jones T, O'Mahany B, et al. A scintigraphic investigation of the precorneal residence time of TS polysaccharide formulations in mild to moderate KCS patients. J Pharm Pharmacol 2002;54:S1-S15.
22. Bhavsar AS, Bhavsar SG, Jain SM. A review on recent advances in dry eye: Pathogenesis and management. Oman J Ophthalmol 2011;4:50-6.
23. Uccello-Barretta G, Nazzi S, Balzano F, Sanso M. A nuclear magnetic resonance approach to the comparison of mucoadhesive properties of polysaccharides for ophthalmic uses. Int J Pharm 2011;406:78-83.
24. Meloni M, De Servi B, Marasco D, Del Prete S. Molecular mechanism of ocular surface damage: application to an in vitro dry eye model on human corneal epithelium. Mol Vis 2011;17:113-26.
25. Mantelli F, Argueso P. Functions of ocular surface mucins in health and disease. Curr Opin Allergy Clin Immunol 2008;8: 477-83.